Life Sciences Strategy & Growth. A top-ranked life sciences analyst who has spent 20 years building market-leading franchises in UK healthcare investment banking. Stef has helped advise and build billion-dollar successes like Oxford Nanopore, bringing essential strategic insight to the Exymes expansion.